The interaction of phospholamban with the sarcoplasmic reticulum calcium pump (SERCA) is a major regulatory axis in cardiac muscle contractility. The prevailing model involves reversible inhibition of SERCA by monomeric phospholamban and storage of phospholamban as an inactive pentamer. However, this paradigm has been challenged by studies demonstrating that phospholamban remains associated with SERCA and that the phospholamban pentamer is required for cardiac contractility. We have previously used two-dimensional crystallization and electron microscopy to study the interaction between SERCA and phospholamban. To further understand this interaction, we compared small helical crystals and large two-dimensional crystals of SERCA in the absence and presence of phospholamban. In both crystal forms, SERCA molecules are organized into identical anti-parallel dimer ribbons. The dimer ribbons pack together with distinct crystal contacts in the helical versus large two-dimensional crystals, which allow phospholamban differential access to potential sites of interaction with SERCA. Nonetheless, we show that a phospholamban oligomer interacts with SERCA in a similar manner in both crystal forms. In the two-dimensional crystals, a phospholamban pentamer interacts with transmembrane segments M3 of SERCA and participates in a crystal contact that bridges neighboring SERCA dimer ribbons. In the helical crystals, an oligomeric form of phospholamban also interacts with M3 of SERCA, though the phospholamban oligomer straddles a SERCA-SERCA crystal contact. We conclude that the pentameric form of phospholamban interacts with SERCA, and that it plays distinct structural and functional roles in SERCA regulation.
INTRODUCTION
Membrane transport by the sarco-endoplasmic reticulum Ca 2+ -ATPase (a.k.a. SERCA) is central to restoring cytosolic calcium levels following intracellular calcium release. In muscle, calcium release from the sarcoplasmic reticulum (SR) leads to contraction. During the subsequent relaxation phase, SERCA transports two cytoplasmic calcium ions into the SR in exchange for two to three luminal protons and at the expense of one molecule of ATP. We currently have an excellent understanding of the SERCA transport cycle from crystallographic studies (reviewed in (1-3) ).
SERCA consists of three cytoplasmic domains (nucleotide-binding, phosphorylation, and actuator domains) connected to a ten-helix transmembrane domain. ATP-binding and phosphoryl-transfer are mediated by the cytoplasmic domains, and the associated conformational changes are coupled to changes in the calcium binding sites located in the transmembrane domain.
Physiologically, SERCA function depends on the differential expression of SERCA isoforms and splice variants, as well as the differential co-expression of small regulatory transmembrane proteins. The SERCA2a isoform is predominantly expressed in cardiac muscle and is regulated by the co-expression of phospholamban (PLN), a 52 amino-acid integral membrane protein that binds to and lowers the apparent calcium affinity of SERCA. In fast-twitch skeletal muscle, SERCA1a is predominantly expressed and is regulated by the co-expression of sarcolipin (SLN), a 31 amino-acid integral membrane protein homologous to PLN. The prevailing model for PLN inhibition of SERCA involves the reversible association of a PLN monomer (4) , which binds to the calcium-free state of SERCA and dissociates under conditions of elevated cytosolic calcium or PLN phosphorylation. This model originated with the observation that monomeric forms of PLN -mutants that disrupt the pentameric assembly of PLN -were better inhibitors of SERCA (5, 6 ). Later, cross-linking (7) and co-immunoprecipitation (8) studies suggested that relief of SERCA inhibition was accompanied by the dissociation of PLN. Monomeric and pentameric forms of PLN were said to be in dynamic equilibrium in the membrane, with the pool of monomers and pentamers influenced by the phosphorylation status of PLN (9) . Finally, the PLN pentamer was described as an inactive storage form (4, 10) , despite the absence of direct experimental evidence.
This paradigm for SERCA inhibition by PLN has been challenged by discrepant results, as well as recent studies that show a persistent association between SERCA and PLN. Initial indications were from co-immunoprecipitation studies (8) and EPR spectroscopy (11) , which 4 demonstrated that phosphorylated PLN did not dissociate from SERCA as expected. Since then, many studies using FRET (12) (13) (14) , EPR (15, 16) , and NMR (17) have reinforced the concept that PLN appears to be a constitutive regulatory subunit of SERCA. In addition, the PLN pentamer is required for normal cardiac development and function (18), despite being described as an inactive storage form. The active roles proposed for the PLN pentamer include a cation selective channel (19, 20) , modulation of PLN phosphorylation (21, 22) , and direct interaction with SERCA (23, 24) .
With regard to this latter point, it is interesting to note that the crystal structure of the SERCA-PLN complex contains two PLN molecules in complex with a single SERCA molecule (25) . While only one PLN molecule directly interacts with SERCA, the structure clearly reveals that an oligomeric form of PLN interacts with SERCA. Recall that PLN is proposed to exist as a dynamic equilibrium of oligomeric states ranging from pentamer to monomer (9) . The crystal structures of the SERCA-PLN and SERCA-SLN complexes revealed a novel calcium-free E1-like state of SERCA (25) (26) (27) . In these structures, the binding groove for PLN formed by transmembrane helices M2, M6 and M9 of SERCA is shallow enough to accommodate oligomeric forms of PLN (27) .
Thus, the interaction potential of PLN oligomers with SERCA remains an outstanding question in the field.
Toward this goal, our laboratory previously showed that PLN pentamers interacted with SERCA in two-dimensional (2D) co-crystals in a manner dependent on the functional state of PLN (23, 24) . The physical interaction in these crystals occurred at an accessory site on SERCA (transmembrane segment M3), yet it bore all the hallmarks normally associated with SERCA inhibition by the PLN monomer -crystal formation depended on the functional, oligomeric and phosphorylation states of PLN. While this suggested that PLN pentamers contribute to SERCA regulation in some unappreciated fashion, uncertainty remained because PLN participates in a crystal contact with SERCA in the large 2D co-crystals. To further examine this SERCA-PLN interaction, we undertook a comparison with helical crystals of the SERCA-PLN complex by electron cryo-microscopy. The site of interaction between SERCA and PLN in the large 2D crystals -the M3 accessory site of SERCA -is involved in a SERCA-SERCA crystal contact in the helical crystals. Since the SERCA-SERCA contact facilitates helical crystal formation, a PLN interaction at this site is not required for crystal formation. Nonetheless, we found transmembrane densities in the helical crystals that were attributable to PLN and associated with M3 of SERCA.
We also demonstrated that the functional effects of PLN on SERCA depend on the stoichiometry, 5 suggesting that PLN oligomers have a unique functional effect on SERCA. Combined, the results support an interaction between PLN pentamers and SERCA, with functional consequences that are distinct from the inhibitory interaction. A molecular model of this SERCA-PLN pentamer complex was generated using protein docking and molecular dynamics simulations.
MATERIALS & METHODS

Materials
All reagents were of the highest purity available: octaethylene glycol monododecyl ether (C12E8; Barnet Products, Englewood Cliff, NJ); egg yolk phosphatidylcholine (EYPC), phosphatidylethanolamine (EYPE) and phosphatidic acid (EYPA) (Avanti Polar Lipids, Alabaster, AL); all reagents used in the coupled enzyme assay including NADH, ATP, PEP, lactate dehydrogenase, and pyruvate kinase (Sigma-Aldrich, Oakville, ON Canada).
Co-reconstitution of PLN and SERCA
Recombinant PLN was expressed and purified as previously described (28) . Lyophilized PLN (100 µg) was suspended in a 100 µl mixture of chloroform-trifluroethanol (2:1) and mixed with lipids (400 µg EYPC, 50 µg EYPE, 50 µg EYPA) from stock chloroform solutions. The peptide-lipid mixture was dried to a thin film under nitrogen gas and desiccated under vacuum overnight. The peptide-lipid mixture was hydrated in buffer (20 mM imidazole pH 7.0; 100 mM KCl; 0.02% NaN3) at 37 °C for 10 min, cooled to room temperature, and detergent-solubilised by the addition of C12E8 (0.2 % final concentration) with vigorous vortexing. Detergent-solubilized SERCA was added (500 µg in a total volume of 500 µl) and the reconstitution was stirred gently at room temperature. Detergent was slowly removed by the addition of SM-2 biobeads (Bio-Rad, Hercules, CA) over a 4-hour time course (final weight ratio of 25 biobeads to 1 detergent).
Following detergent removal, the reconstitution was centrifuged over a sucrose-gradient for 1 h at 100,000g. The resultant layer of reconstituted proteoliposomes was removed, flash-frozen in liquid-nitrogen and stored at -80 °C. The final approximate molar ratios were 120 lipids to 3.5 PLN to 1 SERCA. 
Crystallization conditions
ATPase activity assays of SERCA reconstitutions
ATPase activity of the co-reconstituted proteoliposomes was measured by a coupledenzyme assay over a range of calcium concentrations from 0.1 M to 10 M (30,31). The Vmax (maximal velocity), KCa (apparent calcium affinity) and nH (Hill coefficient) were determined by fitting the data to the Hill equation (Sigma Plot software, SPSS Inc., Chicago, IL). Errors were calculated as the standard error of the mean for a minimum of four independent reconstitutions.
Data processing
The helical crystals datasets have been published (Table 1 & (29, 32) ). The structure from helical crystals of SERCA alone was an average generated from five helical symmetry groups (-22, 6 reference symmetry). The structure from helical crystals of SERCA in the presence of PLN (Asn 27 -Ala mutant; canine sequence) was an average generated from two helical symmetry groups (-27, 9 reference symmetry). Density maps were calculated for the SERCA-PLN helical crystals without enforcing two-fold symmetry. The two molecules composing the unit cell for the control structure (SERCA alone) were masked and aligned by cross-correlation with the corresponding molecules from the SERCA-PLN map. After alignment, the two molecules composing the unit cell for the control structure were summed to generate a single map and back-transformed to crystallographic data to select the most appropriate M3-PLN pentamer complex. The SERCA-PLN pentamer complex was then constructed by superposing the coordinates of the M3 helix onto the crystal structure of the E2·MgF4 2-state of SERCA. The final model was subjected to 5,000 steps of energy minimization.
Molecular dynamics simulations of the SERCA-PLN pentamer complex
The atomistic SERCA-PLN pentamer complex served as a starting structure to obtain a structural model of the complex at physiologically relevant simulation conditions. Based on previous studies of the E2 state of SERCA (34), we modeled transport site residues Glu 309 , Glu 771 and Glu 908 as protonated and residue Asp 800 as ionized. The complex was inserted in a preequilibrated 120 Å 2 bilayer of POPC lipids. This lipid-protein system was solvated using TIP3P
water molecules with a minimum margin of 15 Å between the protein and the edges of the periodic box in the z-axis, and K + and Cl -ions were added (KCl concentration of ~0.1 mM).
To generate a reliable model of the complex, we performed molecular dynamics (MD)
simulations of the fully solvated complex using NAMD 2.12 (35) with periodic boundary conditions (36), particle mesh Ewald (37,38), a non-bonded cut-off of 9 Å, and a 2 fs time step. 8 The CHARMM36 force field topologies and parameters were used for the proteins (39), lipid (40), water, and ions. The NPT ensemble was maintained with a Langevin thermostat (310K) and an anisotropic Langevin piston barostat (1 atm). The system was first subjected to energy minimization, followed by gradually warming up of the system for 200 ps. This procedure was followed by 10 ns of equilibration with backbone atoms harmonically restrained using a force constant of 10 kcal mol -1 Å -2 . The MD simulation of the complex was continued without restraints for 200 ns.
RESULTS
Functional differences between the PLN monomer and pentamer
The PLN-SERCA molar ratio reported for cardiac SR membranes varies from 1:1 (41) µmoles/min/mg) were all statistically significant from one another (p<0.01). This result supports the notion that SERCA activity is influenced by the membrane concentration of PLN (31, 46, 47) .
The dependence of Vmax, but not KCa, on the SERCA-PLN membrane concentration suggests that there are multiple modes of interaction between PLN and SERCA, involving more than a simple one-to-one inhibitory interaction between these proteins.
Crystallization
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Our previous studies of large 2D crystals of the SERCA-PLN complex identified an M3 accessory site with characteristics consistent with a functional interaction (23, 24) . However, these observations contradicted the central dogma that the pentamer is an inactive storage form of PLN.
Because PLN also participated in a crystal contact in the 2D crystals, the relevance of this interaction remained ambiguous. Thus, it became important to determine if the interaction between SERCA and the PLN pentamer is a crystal contact or a natural association. To address this issue, we re-examined helical crystals of the SERCA-PLN complex (29, 32, 48) and compared them to the large 2D crystals (23,24) (Figure 2) . Helical crystals and large 2D crystals are grown from reconstituted proteoliposomes containing either SERCA alone or SERCA in the presence of PLN.
The proteoliposomes readily form crystals when incubated in decavanadate and EGTA buffer (20 mM imidazole, pH 7.4, 100 mM KCl, 5 or 35 mM MgCl2, 0.5 mM EGTA, and 0.25 mM Na3VO4),
followed by several freeze-thaw cycles to promote proteoliposome fusion and the growth of large crystals. Incubation at 4°C produces optimal crystal formation within three to five days.
Importantly, these experimental conditions are identical for the formation of helical and large 2D crystals except for the concentration of magnesium -5 mM MgCl2 promoted the formation of helical crystals and 35 mM MgCl2 promoted the formation of large 2D crystals. The fundamental units of both crystal forms are the well characterized anti-parallel dimer ribbons of SERCA molecules (23, 32) , which are known to be a stable structural element induced by decavanadate in the absence of calcium (49) . However, the SERCA dimer ribbons are organized differently in the helical and large 2D crystals (Figure 3) . Important for this study, the organization of the SERCA dimer ribbons in the helical crystals had a large impact on the pentamer interaction site observed in the large 2D crystals.
Helical versus large 2D crystals
In both crystal forms, the native-like membrane environment is well suited for structural studies of SERCA regulatory complexes (23, 24, 29) . The helical crystals are membrane cylinders (Figure 3) . In comparing the two crystals forms, the inhibitory site on SERCA is accessible in both helical and large 2D crystals, while a SERCA-SERCA crystal contact limits access to the M3 accessory site in the helical crystals.
Helical crystals
In the present study, we reanalyzed the helical crystals of SERCA and PLN (29) in order to identify densities associated with the transmembrane domain of PLN. Recall that our prior studies of the regulatory SERCA-PLN complex using helical crystals at 10 Å resolution provided a well-defined three-dimensional structure for SERCA and weak, discontinuous densities attributable to the cytoplasmic domain of PLN (29) . To observe these PLN densities, it was necessary to calculate difference maps between helical reconstructions of SERCA in the absence and presence of PLN. Nonetheless, a model was proposed in which the cytoplasmic domain of PLN interacted with two SERCA molecules, though no difference densities were observed for the transmembrane helix of PLN (29) .
To improve upon our previous analyses, we hypothesized that a higher-resolution control would facilitate comparison with our SERCA-PLN datasets and lead to the identification of transmembrane densities. A 6 Å resolution structure of SERCA by electron cryo-microscopy was reported, which improved upon our previous control dataset by increasing the number of helical crystals included in the analysis ( Table 1 & (32)). The quality of the resultant density map was sufficient for fitting of SERCA atomic coordinates, which required rigid-body docking of SERCA domains into corresponding regions of the map. This higher-resolution control dataset (SERCA in the absence of PLN) was necessary for the visualization of PLN densities. Second, to identify transmembrane densities, we focused on the highest resolution dataset for SERCA in the presence 11 of PLN (29) . This high-resolution data set of SERCA-PLN helical crystals was enabled by (i) the use of a super-inhibitory pentameric form of PLN (Asn 27 -Ala mutant; canine PLN sequence), (ii) a one-to-3.5 molar ratio of SERCA to PLN, and (iii) the absence of thapsigargin, which has traditionally been used to promote helical crystals.
To determine structural differences in the presence of PLN, we focused on helical crystals of the super-inhibitory pentameric form of PLN (Asn 27 -Ala mutant). The crystallographic data for the control and Asn 27 -Ala datasets have similar two-fold phase statistics as a function of resolution to 8 Å ( Table 1 ). The helical reconstructions for SERCA in the absence and presence of PLN at 8 Å resolution were subjected to two rounds of density scaling and real space alignment, followed by density subtraction to produce a difference map (Figures 4 & 5) . This comparison finally revealed densities attributable to the transmembrane domain of PLN, which could be interpreted in terms of a pseudo-atomic model for SERCA in the helical crystals (32) . A set of densities were found at the M3 accessory site, along a twofold axis that relates a pair of SERCA molecules from neighboring dimer ribbons. The twofold axis corresponds to a crystal contact between SERCA molecules involving M3-M4 loops, where four PLN densities traverse the membrane and straddle a pair of M3 segments (Figure 4) . Similarly, a series of densities were observed at the surface of the membrane, directly above the transmembrane densities ( Figure 5 ). While the densities were consistent with a PLN tetramer, the observed oligomeric state is likely influenced by the twofold axis formed by the SERCA-SERCA crystal contact. An additional weak density was observed adjacent to the PLN tetramer, suggesting partial occupancy of a fifth PLN molecule (i.e. a PLN pentamer; Figure 4 , arrow). Nonetheless, a PLN oligomer was found associating with M3 of SERCA in the helical crystals, which is precisely what was observed in large 2D co-crystals of the SERCA-PLN complex (23, 24) .
Molecular model of the SERCA-PLN pentamer complex
To generate a molecular model of the SERCA-PLN pentamer complex that was representative of the state found in the 2D crystals, we performed protein-protein docking and MD (27) . Thus, the consensus model no longer adequately describes all of the available evidence regarding SERCA-PLN interactions.
Functional consequences of PLN oligomers
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In the present study, the proteoliposomes containing SERCA and PLN provided a welldefined and well-characterized (23, 24, 29, 46, 53) 
Structural consequences of PLN oligomers
The same proteoliposomes used for functional assays were used to generate helical and large 2D crystals of SERCA in the absence and presence of PLN, which formed under relatively simple crystallization conditions. Besides magnesium discussed above, the essential components included EGTA to remove calcium and decavandate to induce formation of the SERCA dimer ribbons. The removal of calcium promotes an E2, calcium-free state of SERCA that is compatible with PLN binding. Decavanadate interacts with SERCA at two sites, one that encompasses the nucleotide binding site and a second site that bridges the actuator domains of two SERCA molecules and thereby stabilizes the antiparallel dimer ribbons (56).
Our initial finding that PLN pentamers interacted with SERCA in large 2D crystals was a surprise (23) . At the time, the simplest explanation was that the PLN pentamer makes a crystal contact with SERCA that is not relevant to the function of these two proteins. However, subsequent With this small change in magnesium, a major difference between the helical and large 2D crystals was the accessibility of transmembrane segment M3 of SERCA. In the helical crystals, M3 is involved in a SERCA-SERCA crystal contact, which is absent in the large 2D crystals. Thus, the helical crystals offer limited access to the M3 accessory site, while this site is accessible in the large 2D crystals. Despite the limited access to M3 in the helical crystals, an oligomeric form of PLN was found straddling the M3 transmembrane segments of adjacent SERCA molecules (Figure 4) . Four discreet transmembrane densities were found, which correspond to the transmembrane helices of a PLN tetramer. The evidence for the densities corresponding to PLN include: (i) the size and density of each peak (~3.5 σ) are consistent with transmembrane helices;
(ii) besides SERCA, the only other protein present in the co-reconstituted proteoliposomes is PLN (at ~1-to-3.5 SERCA-PLN molar ratio); and (iii) we know that PLN is present in the crystal lattice because an anti-PLN monoclonal antibody disrupts crystallization (29) . We observed four densities rather than the five expected for a PLN pentamer; however, the PLN oligomer sits across a two-fold axis and this must influence the interaction and the observed densities. There is an adjacent fifth density (Figure 4) , though it is weak and may represent partial occupancy of an additional PLN molecule. We also observed four densities at the surface of the membrane (equivalent to the cytosolic side of the SR membrane), situated above each of the PLN transmembrane densities (Figure 5 ). These densities are consistent with the N-terminal α-helix of 15 PLN and molecular models that place it at the membrane surface (17, 57) . In this case, the PLN oligomer does not appear to interact with M10 of SERCA or another PLN oligomer, as was observed in the large 2D crystals. Thus, the data presented herein indicate that PLN associates with the M3 accessory site of SERCA independent of crystal contacts (Figure 6 ).
The PLN pentamer and SERCA activity
The increased maximal activity of SERCA in the presence of PLN pentamers has been shown to be sensitive to mutation and the oligomeric state of PLN (46, 47) . Here we show that the increase in the maximal activity of SERCA depends on the abundance of PLN pentamers in the same proteoliposomes used for 2D crystallization (Figure 1) . The maximal activity of SERCA was measured for each proteoliposome preparation to confirm the functional effect of the PLN pentamer, and the remainder of the proteoliposomes were subjected to crystallization trials. Thus, we can consider the interaction in the helical and large 2D crystals in the context of the effect on the maximal activity of SERCA.
There are two well-known mechanisms for increasing the maximal activity of SERCA. The first is to solubilize SERCA in the detergent C12E8 (58, 59) , which frees SERCA from the lateral constraints of the lipid bilayer and increases its maximal activity approximately two-fold. The second is to reconstitute SERCA in the presence of a mixture of lipids including phosphatidylcholine, phosphatidylethanolamine (PE), and phosphatidic acid (PA). The addition of lipids that mildly destabilize the bilayer (PE & PA) also increase SERCA's maximal activity (53, 60) . With this context in mind, the observed physical interaction between the PLN pentamer and SERCA offers a plausible explanation for the stimulation of SERCA's maximal activity. The M3 accessory site lines the calcium entry funnel of SERCA, formed by transmembrane segments M1 and M2. In particular, the transmembrane densities (Figure 4 ) and the membrane-surface densities surround this calcium access funnel (asterisks in Figure 5 ). The cytoplasmic domain of PLN is highly basic and lies along the membrane surface (17) . As such, it would be expected to perturb lipid packing adjacent to the calcium access funnel and transmembrane segments M1 and M2 of SERCA. This region of SERCA is highly mobile in the SERCA transport cycle, and the membrane perturbation may facilitate movement of transmembrane helices and thereby increase the turnover rate of SERCA. Thus, the interaction of PLN observed in the 2D crystals offers a plausible explanation for the effect on SERCA's maximal activity. 16 As mentioned above, the affect of PLN on the maximal activity of SERCA is sensitive to PLN mutation. Merging our current findings with previous mutagenesis studies revealed that particular residues in the primary structure of PLN, when mutated to alanine, reduced the maximal activity of SERCA (31, 44, 46 (44) . The modulation of charged residues in the cytoplasmic domain would be expected to alter the amphipathic membrane interactions of PLN. Together with the coordinated positioning of the cytoplasmic and transmembrane domains of PLN, these observations are consistent with the hypothesis that membrane perturbation may facilitate a more rapid turnover rate for SERCA.
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